Pharma industry officials say the revised Schedule M regulations could require Rs 10-15 crore per facility in upgrades, while talent shorta...

The administration’s decision comes in the wake of growing concerns raised by civil society, religious organizations, and medical experts r...

India's drug regulator is creating new rules for dangerous solvents in children's medicines. This follows tragic deaths linked to contamina...

India's drug regulator CDSCO has issued new rules for drug safety reporting. Companies must now submit safety reports from the actual launc...

India's drug regulator has released draft guidelines for biosimilar drugs, inviting public comments within 30 days. These revised regulatio...

Cosmetics samples were not collected in some regions. There is no centralised database of sale outlets where "not-of-standard" quality (NSQ...

The document states the draft regulatory guidelines for sampling of drugs, cosmetics and medical devices by drugs inspectors of central and...

The CBI has arrested Joint Drugs Controller S Eswara Reddy, Associate Vice President of Biocon Biologics L Praveen Kumar and three others i...

The Centre has also allowed foreign vaccines included in the emergency use listing maintained by the World Health Organisation to be fast-t...

Dinesh Thakur says the country needs strict criminal prosecution against suppliers of substandard drugs, a nationwide product recall system.

In his report, Thakur suggested greater empowerment for the central administration by amending certain legal provisions like Drugs and Cosm...

As online shopping catches up, you could buy medicines too with a click of the mouse for which the health ministry is evaluating a proposal.

The state should have a robust procurement, logistics and supply chain system that is backed by Information technology.

A lobby group of biotech drug companies in India has raised concerns about the approval of Cipla's first biosimilar drug Etanercept.

Drugs derived from plants will soon have to go through a strict regulatory process to improve their acceptance on the global stage.

The department of biotechnology (DBT) is planning to set up the National Biotechnology Regulatory Board to specify and regulate development...

A year ago, the Drugs Controller General Of India’s office, the frontline regulatory outfit of the Central Drug Standard Control Organisati...